Logo image of SNES

SENESTECH INC (SNES) Stock Fundamental Analysis

NASDAQ:SNES - Nasdaq - US81720R6045 - Common Stock - Currency: USD

2.75  +0.07 (+2.61%)

After market: 2.73 -0.02 (-0.73%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to SNES. SNES was compared to 197 industry peers in the Pharmaceuticals industry. SNES has a bad profitability rating. Also its financial health evaluation is rather negative. SNES is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SNES has reported negative net income.
In the past year SNES has reported a negative cash flow from operations.
In the past 5 years SNES always reported negative net income.
In the past 5 years SNES always reported negative operating cash flow.
SNES Yearly Net Income VS EBIT VS OCF VS FCFSNES Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

SNES has a worse Return On Assets (-165.94%) than 87.31% of its industry peers.
SNES has a worse Return On Equity (-208.06%) than 69.54% of its industry peers.
Industry RankSector Rank
ROA -165.94%
ROE -208.06%
ROIC N/A
ROA(3y)-145.81%
ROA(5y)-129.68%
ROE(3y)-183.8%
ROE(5y)-169.9%
ROIC(3y)N/A
ROIC(5y)N/A
SNES Yearly ROA, ROE, ROICSNES Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

1.3 Margins

The Gross Margin of SNES (61.34%) is better than 69.54% of its industry peers.
SNES's Gross Margin has improved in the last couple of years.
SNES does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.57%
GM growth 5Y13.61%
SNES Yearly Profit, Operating, Gross MarginsSNES Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

3

2. Health

2.1 Basic Checks

SNES does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SNES has been increased compared to 1 year ago.
The number of shares outstanding for SNES has been increased compared to 5 years ago.
SNES has a worse debt/assets ratio than last year.
SNES Yearly Shares OutstandingSNES Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
SNES Yearly Total Debt VS Total AssetsSNES Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -53.31, we must say that SNES is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SNES (-53.31) is worse than 92.89% of its industry peers.
SNES has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.07, SNES perfoms like the industry average, outperforming 54.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z -53.31
ROIC/WACCN/A
WACC10.01%
SNES Yearly LT Debt VS Equity VS FCFSNES Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

SNES has a Current Ratio of 5.83. This indicates that SNES is financially healthy and has no problem in meeting its short term obligations.
SNES's Current ratio of 5.83 is fine compared to the rest of the industry. SNES outperforms 76.65% of its industry peers.
SNES has a Quick Ratio of 4.44. This indicates that SNES is financially healthy and has no problem in meeting its short term obligations.
SNES's Quick ratio of 4.44 is fine compared to the rest of the industry. SNES outperforms 69.54% of its industry peers.
Industry RankSector Rank
Current Ratio 5.83
Quick Ratio 4.44
SNES Yearly Current Assets VS Current LiabilitesSNES Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

7

3. Growth

3.1 Past

SNES shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.76%, which is quite impressive.
Looking at the last year, SNES shows a very strong growth in Revenue. The Revenue has grown by 39.64%.
SNES shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 67.70% yearly.
EPS 1Y (TTM)96.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.03%
Revenue 1Y (TTM)39.64%
Revenue growth 3Y45.73%
Revenue growth 5Y67.7%
Sales Q2Q%16.87%

3.2 Future

SNES is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.28% yearly.
SNES is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 76.45% yearly.
EPS Next Y36.16%
EPS Next 2Y18.6%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue Next Year103.47%
Revenue Next 2Y91.38%
Revenue Next 3Y76.45%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SNES Yearly Revenue VS EstimatesSNES Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
SNES Yearly EPS VS EstimatesSNES Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -10K -20K -30K -40K -50K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SNES. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNES. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNES Price Earnings VS Forward Price EarningsSNES Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNES Per share dataSNES EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8

4.3 Compensation for Growth

SNES's earnings are expected to grow with 14.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.6%
EPS Next 3Y14.28%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SNES!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SENESTECH INC

NASDAQ:SNES (5/29/2025, 8:14:24 PM)

After market: 2.73 -0.02 (-0.73%)

2.75

+0.07 (+2.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-07 2025-05-07
Earnings (Next)08-06 2025-08-06
Inst Owners2.2%
Inst Owner Change59.42%
Ins Owners0.02%
Ins Owner Change0%
Market Cap4.89M
Analysts82.86
Price Target10.2 (270.91%)
Short Float %9.31%
Short Ratio1.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.54
P/FCF N/A
P/OCF N/A
P/B 1.69
P/tB 1.69
EV/EBITDA N/A
EPS(TTM)-9.97
EYN/A
EPS(NY)-5.92
Fwd EYN/A
FCF(TTM)-3.3
FCFYN/A
OCF(TTM)-3.24
OCFYN/A
SpS1.08
BVpS1.62
TBVpS1.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -165.94%
ROE -208.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.34%
FCFM N/A
ROA(3y)-145.81%
ROA(5y)-129.68%
ROE(3y)-183.8%
ROE(5y)-169.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.57%
GM growth 5Y13.61%
F-Score3
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 74.68%
Cap/Sales 6.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.83
Quick Ratio 4.44
Altman-Z -53.31
F-Score3
WACC10.01%
ROIC/WACCN/A
Cap/Depr(3y)86.22%
Cap/Depr(5y)65.99%
Cap/Sales(3y)11.23%
Cap/Sales(5y)18.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.03%
EPS Next Y36.16%
EPS Next 2Y18.6%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue 1Y (TTM)39.64%
Revenue growth 3Y45.73%
Revenue growth 5Y67.7%
Sales Q2Q%16.87%
Revenue Next Year103.47%
Revenue Next 2Y91.38%
Revenue Next 3Y76.45%
Revenue Next 5YN/A
EBIT growth 1Y19.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.9%
EBIT Next 3Y19.27%
EBIT Next 5YN/A
FCF growth 1Y32.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.78%
OCF growth 3YN/A
OCF growth 5YN/A